GS
Glenn Steele Jr MD PhD sold $782K of PTCT stock
Glenn Steele Jr MD PhD, Dir of Ptc Therapeutics, Inc. (PTCT), sold 12,000 shares of PTCT stock worth $782K, per an SEC Form 4 filed Oct 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 30, 2026, 2 days before it was made public.
PTCT has moved -2.0% since the trade date, from $64.78 to $63.49 (Nov 13, 2026 close).
- Traded
- Sep 30, 2026
- Disclosed
- Oct 2, 2026
- Filing delay
- 2 days
- Price since
- -2.0%
- Role
- Dir
- Source
- SEC Form 4